Lurasidone HCl - A Long Term Phase 3 Study of Patients With Chronic Schizophrenia

Clinical trial NCT00789698 · COMPLETED

Trial details

NCT number: NCT00789698
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Schizophrenia

Start date: 2008-12-01
Primary completion: 2011-07-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.